Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Hormone Disorder”

760 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 760 results

Large-scale testing (Phase 3)Study completedNCT00390455
What this trial is testing

Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive

Who this might be right for
Estrogen Receptor PositiveHER2 Positive Breast CarcinomaHER2/Neu Negative+5 more
National Cancer Institute (NCI) 295
Testing effectiveness (Phase 2)UnknownNCT04318223
What this trial is testing

Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal Therapy

Who this might be right for
Metastatic Breast CancerLocally Advanced Breast Cancer
Consorzio Oncotech 168
Large-scale testing (Phase 3)WithdrawnNCT00256555
What this trial is testing

Growth Hormone Treatment Study in Children With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
University of Texas Southwestern Medical Center
Testing effectiveness (Phase 2)UnknownNCT04034589
What this trial is testing

Pyrotinib in Combination With Fulvestrant in Patients With HER2 Positive，HR-Positive Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 46
Not applicableStudy completedNCT01263457
What this trial is testing

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in the UK

Who this might be right for
Growth Disorders
Merck KGaA, Darmstadt, Germany 191
Not applicableStudy completedNCT01616095
What this trial is testing

Effects of Growth Hormone Supplementation to Adults With Growth Hormone Deficient on Metabolism and Adipose Tissue Molecular Phenotype

Who this might be right for
Growth Hormone Deficiency
Slovak Academy of Sciences 44
Testing effectiveness (Phase 2)WithdrawnNCT01537094
What this trial is testing

The Effect of Vitamin C on Growth Hormone Secretion

Who this might be right for
ObeseDisorder of Vitamin CGrowth Hormone Secretion Abnormality
Massachusetts General Hospital
Not applicableStudy completedNCT01200875
What this trial is testing

Performance-Enhancing Effects of Platelet-Rich Plasma (PRP) Injections

Who this might be right for
TendinopathyRheumatic Diseases
Stanford University 25
Not applicableStudy completedNCT07026812
What this trial is testing

Impact of Screens on Children's Growth

Who this might be right for
Growth Disorders
University Hospital, Rouen 150
Not applicableStudy completedNCT04508673
What this trial is testing

Impact of GH Measurements on GHD Diagnosis

Who this might be right for
Growth Hormone Deficiency
University Hospital, Montpellier 41
Testing effectiveness (Phase 2)Study completedNCT00130286
What this trial is testing

Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance

Who this might be right for
HIV-Associated Lipodystrophy SyndromeInsulin ResistanceHIV Infections+2 more
Weill Medical College of Cornell University 77
Not applicableStudy completedNCT00324064
What this trial is testing

Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing

Who this might be right for
Growth Hormone Deficiency
Children's Mercy Hospital Kansas City 90
Post-approval studies (Phase 4)Ended earlyNCT00555009
What this trial is testing

Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury

Who this might be right for
Brain InjuriesGrowth Hormone Deficiency
Pfizer 10
Testing effectiveness (Phase 2)UnknownNCT00837863
What this trial is testing

Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency

Who this might be right for
Growth Hormone Deficiency
Altus Pharmaceuticals 36
Not applicableWithdrawnNCT00287430
What this trial is testing

Growth Hormone Use in Adolescents and Adults With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
University of Texas Southwestern Medical Center
Large-scale testing (Phase 3)Study completedNCT01813630
What this trial is testing

A Clinical Study to Assess the Efficacy and Safety of DA-3002

Who this might be right for
Turner's Syndrome
Dong-A ST Co., Ltd. 58
Large-scale testing (Phase 3)Study completedNCT00294619
What this trial is testing

Treatment of Adults With Growth Hormone Deficiency

Who this might be right for
Pituitary DisordersAdult Growth Hormone Deficiency
LG Life Sciences 147
Testing effectiveness (Phase 2)Study completedNCT02235987
What this trial is testing

Single Dose Pharmacology Study of DG3173 and Octreotide in Acromegalic Patients.

Who this might be right for
Acromegaly
Aspireo Pharmaceuticals Limited 20
Post-approval studies (Phase 4)WithdrawnNCT03988114
What this trial is testing

Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Eli Lilly and Company
Testing effectiveness (Phase 2)WithdrawnNCT01647412
What this trial is testing

Growth Hormone and Exclusion Diet Therapy in Juvenile Crohn's Disease

Who this might be right for
Crohn's Disease
Columbia University
Load More Results